Filing Flows › Accendra Health (ACH) › Stock forecast & fair value
Accendra Health (ACH) stock forecast and price target
Accendra Health (ACH) trades at $0.20. 4 analysts' median price target is $1.40 (+589%), from $0.50 to $1.75.
Accendra Health's latest quarter
Accendra Health, Q3 2026: revenue $602M (-14% year over year), operating margin 0.2%, net loss $19.7M, operating cash flow −$17.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for ACH stock?
The median of 4 analysts' 12-month targets is $1.40, +589% from $0.20; the range is $0.50 to $1.75. The average rating is hold.
Does Accendra Health usually beat earnings estimates?
It beat the consensus EPS estimate in 40% of the quarters on record.
Is ACH stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.